Estratest Related Published Studies
Well-designed clinical trials related to Estratest (Esterified Estrogens)
Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses. [2007.03]
Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. [2005.07]
Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women. [2005.06]
Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. [2004.05]
Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. [2003.06]
Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. [2001.07]
Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study. [2000.11]
Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. [2000.09]
Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group. [1997.12.08]
[Comparison of the relative bioavailability and pharmacokinetics of estrone after oral administration of esterified estrogens in a tablet formulation and an aqueous suspension] [1997.02]
A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. [1993.12]
Well-designed clinical trials possibly related to Estratest (Esterified Estrogens)
Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women. [2005.04]
A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. [1999.12]
Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. [1999.06]
Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. [1998.10]
Enterohepatic cycling and pharmacokinetics of oestradiol in postmenopausal women. [1998.08]
Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. [1998.05]
Vasodilator effects of estrogen are not diminished by androgen in postmenopausal women. [1997.12]
Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. [1995.04]
A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy. [1992.08]
Other research related to Estratest (Esterified Estrogens)
Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women. [2006.12]
Esterified estrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women. [2006.09]
The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women. [2006.08]
Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. [2006.02.27]
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. [2004.10.06]
Estratest and Estratest HS (esterified estrogens and methyltestosterone) therapy: a summary of safety surveillance data, January 1989 to August 2002. [2003.12]
Low-dosage esterified estrogens opposed by progestin at 6-month intervals. [2001.08]
[Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico] [2001.05]
Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting. [2000.09]
Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States. [1997.09]
Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. [1996.12]
Other possibly related research studies
Low-dose estrogen therapy for menopausal women: a review of efficacy and safety. [2003.10]
HRT dosing regimens: continuous versus cyclic-pros and cons. [2001.01]
[Basic principles of hormone replacement therapy in the postmenopause] [2000.10]
Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995. [2000.08]
Role of the ovary in the adrenal androgen excess of hyperandrogenic women. [1998.05]
Influence of estrogen plus testosterone supplementation on breast cancer. [2009.01.12]
Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. [2009.01]
|
